Valuation: Tiansheng Pharmaceutical Group Co., Ltd.

Market Cap 1.61B 239M 206M 192M 177M 334M 22.7B 338M 2.26B 886M 11.35B 897M 877M 37.64B P/E 2024
-16.5x
P/E 2025 -27.9x
Enterprise Value 1.69B 250M 216M 202M 186M 350M 23.82B 355M 2.37B 929M 11.9B 941M 920M 39.49B EV / Sales 2024
2.7x
EV / Sales 2025 3.16x
Free-Float
52.84%
Yield 2024 *
-
Yield 2025 -
05-08 Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement MT
04-28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-12 Three Tiansheng Pharma Drugs Set to Win Bids for China's Drug Procurement Program MT
11-07 Tiansheng pharmaceutical and its controlling shareholder penalised, fined RE
25-10-29 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-10-14 Tiansheng Pharmaceutical Group Subsidiaries Tentatively Win Bulk Drug Tenders in Guangdong MT
25-09-15 Tiansheng Pharmaceutical Gets China Supplementary Drug Approval for Sodium Bicarbonate Injection MT
25-08-27 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-04-28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-02-10 Tiansheng Pharmaceutical Passes Consistency Evaluation for Antibiotic MT
24-12-25 Chongqing Pharmaceutical Group Changsheng Pharmaceutical Co., Ltd announced that it expects to receive CNY 60 million in funding from C.Q. Pharmaceutical Holding Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd. CI
1 day+0.20%
1 week+3.27%
Current month+2.22%
1 month+0.60%
3 months-6.64%
6 months+4.12%
Current year+4.12%
1 week 4.88
Extreme 4.88
5.13
1 month 4.5
Extreme 4.5
5.13
Current year 4.32
Extreme 4.32
5.65
1 year 4.32
Extreme 4.32
5.81
3 years 3.17
Extreme 3.17
5.97
5 years 3.17
Extreme 3.17
5.99
10 years 3.17
Extreme 3.17
35.18
Manager TitleAgeSince
Chief Executive Officer 33 2018-12-05
Director of Finance/CFO 52 2013-12-22
Corporate Officer/Principal 54 2020-12-10
Director TitleAgeSince
Chairman 33 2018-12-05
Director/Board Member 54 2020-12-10
Director/Board Member 66 2020-12-10
Date Insider Type Main position Quantity % Market Cap.
7/25/23 Sell

Chief Financial Officer

43,100 0.0205%
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%+3.27%+6.08%-3.44% 238M
+4.86%-4.16%+52.13%+160.26% 995B
+1.04%-3.43%+50.60%+52.38% 614B
+0.98%-6.46%+24.85%+66.66% 431B
+1.96%-0.87%+43.02%+37.60% 353B
-0.11%-4.56%+31.59%+39.73% 293B
+2.52%-6.99%+8.08%+10.32% 245B
+4.57%+3.75%+35.07%+67.64% 210B
-4.32%-12.25%-5.97%-44.56% 210B
-2.58%-1.91%+15.06%+67.46% 168B
Average +0.80%-4.17%+26.05%+45.41% 351.85B
Weighted average by Cap. +0.73%-5.89%+36.58%+75.03%

Financials

2024 2025
Net sales 570M 84.52M 73.01M 68.07M 62.63M 118M 8.04B 120M 800M 314M 4.02B 317M 310M 13.33B 514M 76.27M 65.88M 61.42M 56.52M 107M 7.25B 108M 722M 283M 3.63B 286M 280M 12.03B
Net income -87.4M -12.97M -11.2M -10.44M -9.61M -18.13M -1.23B -18.37M -123M -48.12M -616M -48.7M -47.62M -2.04B -55.42M -8.22M -7.1M -6.62M -6.09M -11.5M -782M -11.65M -77.83M -30.52M -391M -30.88M -30.2M -1.3B
Net Debt 97.19M 14.42M 12.45M 11.61M 10.68M 20.16M 1.37B 20.43M 136M 53.51M 685M 54.15M 52.96M 2.27B 78.93M 11.71M 10.11M 9.43M 8.68M 16.37M 1.11B 16.59M 111M 43.46M 557M 43.98M 43.01M 1.85B
Logo Tiansheng Pharmaceutical Group Co., Ltd.
Tiansheng Pharmaceutical Group Co Ltd is a China-based company primarily engaged in drug R&D, production, sales, and the cultivation and processing of traditional Chinese medicinal materials. The Company's products include tablets, capsules, granules, teas, pills, and injections. Product varieties cover pediatrics, gynecology, cardiovascular system, digestive system, orthopedics, respiratory medicine, and anti-infective treatment areas. The Company's products are mainly sold to the domestic market.
Employees
1,273
Date Price Change Volume
26-08-05 CN¥5.060 +0.20% 2,047,400
26-08-04 CN¥5.050 0.00% 2,688,100
26-08-03 CN¥5.050 +2.02% 1,594,750
26-07-31 CN¥4.950 +1.23% 1,487,950
26-07-30 CN¥4.890 -0.81% 1,216,800
  1. Stock Market
  2. Stocks
  3. 002872 Stock